METTL1 and glioblastoma: The loss of METTL1 results in decreased m7G tRNA methylation and expression, inhibition of cell cycle and global translation, as well as the growth of tumors cell in many types, such as melanoma, liposarcoma (LPS), glioblastoma multiforme (GBM), and acute myeloid leukemia (AML).